antimycin a has been researched along with Malaria, Falciparum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biagini, GA; Chuawong, P; Fisher, N; Grigg, R; Hasitapan, K; Hunte, C; Kao, WC; Kongkathip, B; Kongkathip, N; Kongsaeree, P; Pradidphol, N; Warman, AJ | 1 |
| Clardy, J; Derbyshire, ER; Mota, MM; Prudêncio, M | 1 |
2 other study(ies) available for antimycin a and Malaria, Falciparum
| Article | Year |
|---|---|
Transforming rhinacanthin analogues from potent anticancer agents into potent antimalarial agents.
Topics: Animals; Antimalarials; Antineoplastic Agents; Cell Survival; Chlorocebus aethiops; Electron Transport Complex III; Erythrocytes; Inhibitory Concentration 50; Malaria, Falciparum; Male; Mitochondrial Membranes; Naphthoquinones; Plasmodium falciparum; Rats; Rats, Wistar; Saccharomyces cerevisiae; Structure-Activity Relationship; Vero Cells | 2010 |
Liver-stage malaria parasites vulnerable to diverse chemical scaffolds.
Topics: Animals; Anopheles; Antimalarials; Drug Evaluation, Preclinical; Hep G2 Cells; Humans; Inhibitory Concentration 50; Insect Vectors; Life Cycle Stages; Liver; Malaria; Malaria, Falciparum; Male; Mice; Mice, Inbred C57BL; Plasmodium berghei; Plasmodium falciparum; Treatment Outcome | 2012 |